Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Felix Falkenberg"'
Autor:
Aaron Uthoff, Seth Lenetsky, Reid Reale, Felix Falkenberg, Gavin Pratt, Dean Amasinger, Frank Bourgeois, Micheál Cahill, Duncan French, John Cronin
Publikováno v:
Strength & Conditioning Journal. 45:67-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cff84a27adaa144a7e980b2375554986
https://doi.org/10.1519/ssc.0000000000000705
https://doi.org/10.1519/ssc.0000000000000705
Autor:
Jochen Fracowiak, Tatjana Huebner, Steffen Heß, Christoph Roethlein, Daria Langner, Udo Schneider, Felix Falkenberg, Catharina Scholl, Roland Linder, Julia Stingl, Britta Haenisch, Michael Steffens
Publikováno v:
The pharmacogenomics journal, 22(2):136-144
The pharmacogenomics journal 22(2), 136-144 (2022). doi:10.1038/s41397-022-00268-6
The pharmacogenomics journal 22(2), 136-144 (2022). doi:10.1038/s41397-022-00268-6
The pharmacogenomics journal 22(2), 136-144 (2022). doi:10.1038/s41397-022-00268-6
Published by Nature Publishing Group, Basingstoke
Published by Nature Publishing Group, Basingstoke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4eb064138172bb105469107ffdf5779
Autor:
Willy Gomm, Daria Langner, Julia C. Stingl, Tatjana Huebner, Britta Haenisch, Felix Falkenberg, Roland Linder, Marco Garling, Jochen Fracowiak, Christoph Roethlein, Michael Steffens
Publikováno v:
Open Heart 10(4), e032624 (2020). doi:10.1136/bmjopen-2019-032624
BMJ Open
BMJ Open
IntroductionPre-emptive testing of pharmacogenetically relevant single-nucleotide polymorphisms can be an effective tool in the prevention of adverse drug reactions and therapy resistance. However, most of the tests are not used as standard in routin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e3f7a70db54a17b92dcb39ab843ed7
Autor:
Ronja, Foraita, Louis, Dijkstra, Felix, Falkenberg, Marco, Garling, Roland, Linder, René, Pflock, Mariam R, Rizkallah, Markus, Schwaninger, Marvin N, Wright, Iris, Pigeot
Publikováno v:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 61(9)
Adverse drug reactions are among the leading causes of death. Pharmacovigilance aims to monitor drugs after they have been released to the market in order to detect potential risks. Data sources commonly used to this end are spontaneous reports sent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::931233c7861d915c5ca2ac5e1e5ac28a
https://pubmed.ncbi.nlm.nih.gov/30027343
https://pubmed.ncbi.nlm.nih.gov/30027343
Autor:
Iris Pigeot, Marco Garling, Markus Schwaninger, Marvin N. Wright, Roland Linder, René Pflock, Louis Dijkstra, Felix Falkenberg, Mariam R Rizkallah, Ronja Foraita
Publikováno v:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 61:1075-1081
Adverse drug reactions are among the leading causes of death. Pharmacovigilance aims to monitor drugs after they have been released to the market in order to detect potential risks. Data sources commonly used to this end are spontaneous reports sent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a077e155a228ec08b1708daa0e4a385
https://repository.publisso.de/resource/frl:6421679
https://repository.publisso.de/resource/frl:6421679
Autor:
Felix Falkenberg, Gottfried Koch
Publikováno v:
Zeitschrift für die gesamte Versicherungswissenschaft. 94:19-56
Wahrend eine ganze Reihe von „New Economy-Unternehmen” in der Versicherungswirtschaft prosperieren, sind viele von ihnen nach nur kurzer Lebensdauer wieder vom Markt. Was sind die wesentlichen Rahmenbedingungen fur den Erfolg dieser Unternehmen?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f776b04b98d8aeea55695553159fa90c
https://doi.org/10.1007/bf03353461
https://doi.org/10.1007/bf03353461